Back to DYN
FCPM III SERVICES B.V. DYN Position History
Dyne Therapeutics, Inc. • Healthcare
Quarters held
8
Latest value
$34.8M
Q3 2026
Peak value
$79M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $27.9M |
| Q4 2025 | $79M |
| Q1 2026 | $25.9M |
| Q1 2026 | $58.3M |
| Q2 2026 | $31.7M |
| Q2 2026 | $53.8M |
| Q3 2026 | $23M |
| Q3 2026 | $34.8M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $34.8M | 2.16M | — | — |
| Q3 2026 | $23M | 1.43M | — | — |
| Q2 2026 | $53.8M | 2.42M | — | — |
| Q2 2026 | $31.7M | 1.43M | — | — |
| Q1 2026 | $58.3M | 3.22M | — | — |
| Q1 2026 | $25.9M | 1.43M | — | — |
| Q4 2025 | $79M | 4.04M | — | — |
| Q4 2025 | $27.9M | 1.43M | — | — |
Other funds holding DYN
$269.8M
$245.6M
$245.6M
$244.3M
Other FCPM III SERVICES B.V. positions
NAMSW
$163.1MNEWAMSTERDAM PHARMA COMPANY
NAMSW
$159.6MNEWAMSTERDAM PHARMA COMPANY
NAMSW
$157.5MNEWAMSTERDAM PHARMA COMPANY
NAMSW
$148.8MNEWAMSTERDAM PHARMA COMPANY
NAMSW
$145.7MNEWAMSTERDAM PHARMA COMPANY
NAMSW
$130.2MNEWAMSTERDAM PHARMA COMPANY
MPLT
$115.6MMAPLIGHT THERAPEUTICS INC
NAMSW
$113MNEWAMSTERDAM PHARMA COMPANY